Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Himmelfarb

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Kidney International|August 5, 1999
Urea: surrogate or toxin?J Himmelfarb
Current Opinion in Nephrology and Hypertension|December 14, 1999
Pharmacologic prevention of vascular access stenosisJ Himmelfarb
Kidney International|January 4, 1998
Dipyridamole inhibits PDGF- and bFGF-induced vascular smooth muscle cell proliferationJ Himmelfarb, L Couper
Kidney International|June 26, 2001
Albumin is the major plasma protein target of oxidant stress in uremiaJ Himmelfarb, E McMonagle
Current Opinion in Nephrology and Hypertension|November 1, 1996
Hemodialysis vascular access: emerging conceptsJ Himmelfarb, T Saad
Blood Purification|January 11, 2001
Manifestations of oxidant stress in uremiaJ Himmelfarb, E McMonagle
Kidney International|October 10, 1998
Hemodialysis access failure: a call to actionR Hakim, J Himmelfarb
Advances in Renal Replacement Therapy|April 1, 1997
The use of biocompatible dialysis membranes in acute renal failureJ Himmelfarb, R M Hakim
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1994
Biocompatibility and risk of infection in haemodialysis patientsJ Himmelfarb, R M Hakim
Journal of Nephrology|March 1, 1997
Dialysis membrane biocompatibility and mortality and morbidity in acute renal failureJ Himmelfarb, R M Hakim
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Kidney International|August 5, 1999
Urea: surrogate or toxin?J Himmelfarb
Current Opinion in Nephrology and Hypertension|December 14, 1999
Pharmacologic prevention of vascular access stenosisJ Himmelfarb
Kidney International|January 4, 1998
Dipyridamole inhibits PDGF- and bFGF-induced vascular smooth muscle cell proliferationJ Himmelfarb, L Couper
Kidney International|June 26, 2001
Albumin is the major plasma protein target of oxidant stress in uremiaJ Himmelfarb, E McMonagle
Current Opinion in Nephrology and Hypertension|November 1, 1996
Hemodialysis vascular access: emerging conceptsJ Himmelfarb, T Saad
Blood Purification|January 11, 2001
Manifestations of oxidant stress in uremiaJ Himmelfarb, E McMonagle
Kidney International|October 10, 1998
Hemodialysis access failure: a call to actionR Hakim, J Himmelfarb
Advances in Renal Replacement Therapy|April 1, 1997
The use of biocompatible dialysis membranes in acute renal failureJ Himmelfarb, R M Hakim
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1994
Biocompatibility and risk of infection in haemodialysis patientsJ Himmelfarb, R M Hakim
Journal of Nephrology|March 1, 1997
Dialysis membrane biocompatibility and mortality and morbidity in acute renal failureJ Himmelfarb, R M Hakim
Pageof 6